# Nyxoah S.A. (NYXH)

> Healthcare · BE · Reports in EUR

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NYXH/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | € 15.04M | € -51.39M | € -40.22M | € 52.57M | € 83.11M |
| 2025 | € 10.18M | € -91.56M | € -70.80M | € 40.48M | € 49.13M |
| 2024 | € 4.68M | € -61.37M | € -57.29M | € 22.65M | € 113.25M |
| 2023 | € 4.61M | € -45.86M | € -59.15M | € 12.70M | € 98.11M |
| 2022 | € 3.37M | € -34.10M | € -49.25M | € 11.88M | € 120.32M |
| 2021 | € 1.02M | € -32.93M | € -44.30M | € 11.68M | € 148.62M |
| 2020 | € 86.4K | € -14.91M | € -13.73M | € 11.54M | € 97.19M |
| 2019 | € 0 | € -10.55M | € -7.47M | € 8.60M | € 2.36M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.63 |
| Liabilities / Eq | 1.03 |
| Current Ratio | 2.38 |

## Other views

- [Metrics](https://sponda.capital/en/NYXH.md)
- [Charts](https://sponda.capital/en/NYXH/charts.md)
- [Compare](https://sponda.capital/en/NYXH/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-30.